Dihydroergotamine (DHE) products contain the following boxed warning:
Serious and life threatening peripheral ischemia have been associated with the use of DHE and use of which of the following:
-Calcium channel blocking drugs
-CYP 3A4 inhibitors
-CYP 3A4 inducers
-CYP 2D6 inhibitors